Legal & Research
Clinical Trial
What is a clinical trial?
A clinical trial is a systematic research study involving human participants, designed to answer specific health-related questions. Clinical trials follow rigorous protocols and are essential for advancing medical knowledge and gaining regulatory approval for new treatments.
Phases of clinical trials:
| Phase | Purpose | Participants | Duration |
|---|---|---|---|
| Phase I | Safety, dosing, side effects | 20–80 healthy volunteers | Months |
| Phase II | Efficacy, side effects | 100–300 patients | Months–2 years |
| Phase III | Confirm efficacy, monitor adverse effects | 1,000–3,000+ patients | 1–4 years |
| Phase IV | Post-marketing surveillance | Broader population | Ongoing |
Key features of well-designed clinical trials:
- Randomization — participants are randomly assigned to treatment or control groups
- Blinding — participants and/or researchers don't know who receives treatment vs. placebo
- Control groups — comparison against placebo or existing treatments
- Statistical rigor — pre-defined endpoints and sample sizes
Why it matters for microdosing
Clinical trials are the gold standard for evidence and are crucial for the future of microdosing:
- Current state — while there is extensive anecdotal evidence for microdosing benefits, rigorous clinical trial data is still limited
- Ongoing research — several universities and research organizations are conducting microdosing trials (Imperial College London, University of Chicago, Maastricht University, and others)
- Key findings so far:
- Some trials show improvements in mood and well-being
- Several controlled studies have found results comparable to placebo, suggesting expectancy effects play a significant role
- The relationship between microdosing and cognitive enhancement remains unclear in controlled settings
- Regulatory pathway — clinical trials are required for any future FDA/EMA approval of microdosing as a medical treatment
How it works in practice
As a microdoser, clinical trial literacy helps you:
- Evaluate claims — distinguish between "one study found" and "robust evidence shows"
- Understand limitations — anecdotal reports ≠ clinical evidence; your positive experience is real but may not generalize
- Participate — consider joining clinical trials if available in your area; this contributes to the evidence base
- Stay informed — follow research from reputable institutions and read beyond headlines
- Maintain intellectual honesty — be open to evidence that challenges your beliefs about microdosing
What to watch out for
- Cherry-picking — the microdosing community sometimes highlights positive findings while ignoring null results
- Pre-prints — studies that haven't been peer-reviewed should be treated with extra caution
- Sample size — small studies (n < 50) can show dramatic results that don't replicate in larger trials
- Conflict of interest — some research is funded by organizations with commercial interests in psychedelics
- Media hype — science journalism often oversimplifies or sensationalizes findings